Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Alessi

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
La Clinica Terapeutica|December 21, 2020
Adherence to the three Italian screening in a sample of women (and men) in the Southern ItalyC Genovese, R Squeri, V Alessi, et al.
International Journal of Cardiology|February 22, 2001
The combination ace-inhibitors plus canreonate in patients with anterior myocardial infarction: safety and tolerability studyP Di Pasquale, V Alessi, O Barberi, et al.
Journal of the National Cancer Institute|June 11, 2021
Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung CancerXinan Wang, Biagio Ricciuti, Joao V Alessi, et al.
Giornale Italiano Di Cardiologia|June 1, 1996
[Is the reduction of the plasma levels of endothelin in the acute and sub-acute stage of myocardial infarct one of the beneficial effects of early treatment with ace inhibitors?]P Di Pasquale, V Bucca, S Scalzo, et al.
La Clinica Terapeutica|September 9, 2020
Mediterranean diet: knowledge and adherence in Italian young peopleV La Fauci, V Alessi, D Z Assefa, et al.
Journal for Immunotherapy of Cancer|March 27, 2021
Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC)Biagio Ricciuti, Greg Jones, Mariano Severgnini, et al.
European Radiology|April 26, 2023
Advanced non-small-cell lung cancer treated with first-line pembrolizumab plus chemotherapy: tumor response dynamics as a marker for survivalMizuki Nishino, Xinan Wang, Biagio Ricciuti, et al.
Nature Communications|June 14, 2024
Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancersTaek-Chin Cheong, Ahram Jang, Qi Wang, et al.
HGG Advances|June 21, 2024
Additional impact of genetic ancestry over race/ethnicity to prevalence of KRAS mutations and allele-specific subtypes in non-small cell lung cancerXinan Wang, Kangcheng Hou, Biagio Ricciuti, et al.
NPJ Precision Oncology|March 7, 2026
Graph neural network modeling of spatial tumor-immune interactions identifies prognostic cellular niches in non‑small cell lung cancerKatharina V Hoebel, James R Lindsay, Jennifer Altreuter, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
La Clinica Terapeutica|December 21, 2020
Adherence to the three Italian screening in a sample of women (and men) in the Southern ItalyC Genovese, R Squeri, V Alessi, et al.
International Journal of Cardiology|February 22, 2001
The combination ace-inhibitors plus canreonate in patients with anterior myocardial infarction: safety and tolerability studyP Di Pasquale, V Alessi, O Barberi, et al.
Journal of the National Cancer Institute|June 11, 2021
Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung CancerXinan Wang, Biagio Ricciuti, Joao V Alessi, et al.
Giornale Italiano Di Cardiologia|June 1, 1996
[Is the reduction of the plasma levels of endothelin in the acute and sub-acute stage of myocardial infarct one of the beneficial effects of early treatment with ace inhibitors?]P Di Pasquale, V Bucca, S Scalzo, et al.
La Clinica Terapeutica|September 9, 2020
Mediterranean diet: knowledge and adherence in Italian young peopleV La Fauci, V Alessi, D Z Assefa, et al.
Journal for Immunotherapy of Cancer|March 27, 2021
Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC)Biagio Ricciuti, Greg Jones, Mariano Severgnini, et al.
European Radiology|April 26, 2023
Advanced non-small-cell lung cancer treated with first-line pembrolizumab plus chemotherapy: tumor response dynamics as a marker for survivalMizuki Nishino, Xinan Wang, Biagio Ricciuti, et al.
Nature Communications|June 14, 2024
Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancersTaek-Chin Cheong, Ahram Jang, Qi Wang, et al.
HGG Advances|June 21, 2024
Additional impact of genetic ancestry over race/ethnicity to prevalence of KRAS mutations and allele-specific subtypes in non-small cell lung cancerXinan Wang, Kangcheng Hou, Biagio Ricciuti, et al.
NPJ Precision Oncology|March 7, 2026
Graph neural network modeling of spatial tumor-immune interactions identifies prognostic cellular niches in non‑small cell lung cancerKatharina V Hoebel, James R Lindsay, Jennifer Altreuter, et al.
Pageof 8